Literature DB >> 21812664

Restrictions on the use of prescribing data for drug promotion.

Michelle M Mello1, Noah A Messing.   

Abstract

Mesh：

Year:  2011        PMID： 21812664     DOI： 10.1056/NEJMhle1107678

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Sorrell v. IMS Health: issues and opportunities for informaticians.

Authors:  Carolyn Petersen; Paul Demuro; Kenneth W Goodman; Bonnie Kaplan
Journal:  J Am Med Inform Assoc       Date:  2012-10-27       Impact factor: 4.497

2.  Can access limits on sales representatives to physicians affect clinical prescription decisions? A study of recent events with diabetes and lipid drugs.

Authors:  George A Chressanthis; Pratap Khedkar; Nitin Jain; Prashant Poddar; Michael G Seiders
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-21       Impact factor: 2.885

3.  Predicting cannabis abuse screening test (CAST) scores: a recursive partitioning analysis using survey data from Czech Republic, Italy, the Netherlands and Sweden.

Authors:  Matthijs Blankers; Tom Frijns; Vendula Belackova; Carla Rossi; Bengt Svensson; Franz Trautmann; Margriet van Laar
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

4.  Characterizing the interaction between physicians, pharmacists and pharmaceutical representatives in a middle-income country: A qualitative study.

Authors:  Rima Hajjar; Aya Bassatne; Mohamad Ali Cheaito; Rabie Naser El Dine; Sarah Traboulsy; Fadi Haddadin; Gladys Honein-AbouHaidar; Elie A Akl
Journal:  PLoS One       Date:  2017-09-12       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.